Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categories:

265 Episodes

  1. Beyond the Pain: Diagnosing Fibromyalgia

    Published: 5/17/2024
  2. Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

    Published: 5/11/2024
  3. Mastering Clozapine: Adverse Effect Management

    Published: 5/6/2024
  4. Preventing Depression and Anxiety Relapse in Youth

    Published: 5/1/2024
  5. Charting the Clozapine Course: Titration and Monitoring

    Published: 4/26/2024
  6. Smoking and Psychosis: Insights from the PATH Study

    Published: 4/21/2024
  7. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Published: 4/16/2024
  8. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Published: 4/11/2024
  9. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Published: 4/6/2024
  10. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Published: 4/1/2024
  11. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Published: 3/27/2024
  12. Olanzapine in Pregnancy: Examining the Risks

    Published: 3/22/2024
  13. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Published: 3/17/2024
  14. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Published: 3/12/2024
  15. Beyond Medication: Exploring Nutritional Psychiatry

    Published: 3/7/2024
  16. Age Impact on Antidepressant Outcomes

    Published: 3/2/2024
  17. Dealing With Delirium in Patients With Advanced Cancer

    Published: 2/26/2024
  18. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Published: 2/21/2024
  19. Managing Anxiety in Patients With Cancer

    Published: 2/16/2024
  20. Managing Antidepressant Side Effects in Youth

    Published: 2/11/2024

4 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.